Why LIC IPO is unlikely this fiscal

A lot of work is needed to be done on the part of the insurance sector behemoth, and the government, before it is ready for its market debut. The much-awaited initial public offering (IPO) of Life Insurance Corporation of India (LIC) is unlikely to happen this financial year, primarily due to an expected delay in […]

Treasury yields muted with pandemic, stimulus and Powell testimony on focus

The passage of a fresh coronavirus relief bill through Congress could be delayed further as President Donald Trump tries to push through a Supreme Court replacement for the late Justice Ruth Bader Ginsburg ahead of the election on November 3. Federal Reserve Chairman Jerome Powell will tell the House of Representatives Financial Services Committee on […]

ABIO Joins Battle Against COVID-19, ERYP On Watch, LPCN To Report NASH Study Results In Q1

Today’s Daily Dose brings you news about ARCA biopharma’s progress related to its COVID-19 drug candidate, ADC Therapeutics’ submission of Loncastuximab tesirine BLA, BridgeBio’s initiation of ADH1 study, ERYTECH Pharma’s anticipated milestones, and the progress in Lipocine’s NASH trial. Read on… 1. ARCA biopharma Joins battle Against COVID-19 ARCA biopharma Inc. (ABIO) has submitted an […]

Xi: The most powerful Chinese ruler in decades

(CNN)A Chinese billionaire who criticized President Xi Jinping’s handling of the coronavirus pandemic has been jailed for 18 years on corruption charges, a court said Tuesday. Ren Zhiqiang, a retired real-estate tycoon with close ties to senior Chinese officials, disappeared in March after he allegedly penned a scathing essay that month criticizing Xi’s response to […]

China’s Xi Swipes at U.S. for Acting Like ‘Boss of the World’

Chinese President Xi Jinping took a veiled swipe at the U.S. in a strongly worded speech, saying no country should “be allowed to do whatever it likes and be the hegemon, bully or boss of the world.” Pushing for developing countries to have a greater role in world affairs, Xi said the United Nations could […]

MRNS Catches Eye, SAVA Soars On Alzheimer’s Study, ETNB Abuzz Over NASH Trial, GILD Snaps Up IMMU

Today’s Daily Dose brings you news about Gilead’s acquisition of Immunomedics, Marinus’ CDKL5 deficiency disorder trial results, Seattle Genetics’ oncology collaborations with Merck, 89bio’s NASH trial data, and Cassava Sciences’ Alzheimer’s trial results. Read on… 1. Cassava Sciences’ Alzheimer’s Trial Data Catches Eye Shares of Cassava Sciences Inc. (SAVA) were up 133% at $7.75 on […]

‘Golden triangle’ dogfight: Rex creates headaches by taking on Qantas and Virgin

One of the more interesting and delicate issues to watch as the economy emerges from the pandemic is how the Australian Competition and Consumer Commission responds to the efforts to recover lost volumes by companies with market power. Given how concentrated many major segments of the economy are, the differences between pro-competitive and anti-competitive behaviours […]

Coca-Cola will enter U.S. hard seltzer market in first half of 2021, CEO says

"I think what it does say is: Look, we're going to follow the consumer," Coca-Cola CEO James Quincey told CNBC's Jim Cramer about the company foray into the fast-growing hard seltzer market. Topo Chico Hard Seltzer, when it launches in the first half of 2021, will be Coca-Cola's first alcoholic beverage in the U.S. since […]